BF Biosciences Limited (KASE: BFBIO)
Health Care · Pharmaceuticals · PK
PKRs135.25
+1.33% today · -19.2% 1Y
BF Biosciences Limited (KASE: BFBIO) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $43.03M.
Over the last twelve months the share price has lost 19.2%, trading between 124.00 and 189.97.
Tweenvest scores BF Biosciences Limited across four factors: quality 63/100, value 72/100. Its strongest factor is value.
BFBIO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $43.03M
- Revenue (TTM)
- $31.76M
- P/E
- 20.19
- EPS
- 6.70
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- PKRs189.97
- 52-week low
- PKRs124.00
- Avg volume (3M)
- —
- Shares outstanding
- 88.33M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,243.27 | -0.29% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $270.91 | -0.78% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.84 | +0.12% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.70 | +0.08% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £122.08 | +0.81% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.89 | -0.29% |
Figures last refreshed Aug 18, 2026.